GlassScriptPhysician profile
Lino B Fernandez
NPI 1881682342
$1,403.81
in general payments reported to CMS, 2019-2025
20 companies · $192 in 2025
The $192 reported for 2025 was more than what a typical Psychiatry provider received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $548 · 2020: $153 · 2023: $322 · 2024: $189 · 2025: $192.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $703.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $703.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $242.99 | 2019 | |
| Shire North American Group INC | $214.48 | 2019 | |
| Vanda Pharmaceuticals INC. | $158.49 | 2024-2025 | Fanapt, Hetlioz |
| Neuronetics, INC. | $131.87 | 2019-2020 | |
| Abbvie INC. | $114.59 | 2023-2024 | |
| Otsuka America Pharmaceutical, INC. | $86.48 | 2023 | Rexulti |
| Takeda Pharmaceuticals U.S.A., INC. | $70.77 | 2020-2025 | Trintellix |
| Janssen Pharmaceuticals, INC | $45.94 | 2019-2023 | Spravato |
| Corium, LLC | $44.84 | 2023 | Azstarys, Azstarys |
| Idorsia Pharmaceuticals US INC | $38.54 | 2023 | Quviviq |
| Supernus Pharmaceuticals, INC. | $38.00 | 2023 | Qelbree |
| Almatica Pharma LLC | $32.28 | 2023-2025 | Loreev Xr |
| E.R. Squibb & Sons, L.L.C. | $26.53 | 2024 | Cobenfy |
| Tris Pharma INC | $24.97 | 2023 | Dyanavel Xr |
| Lundbeck LLC | $24.76 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Noven Therapeutics, LLC | $24.62 | 2024 | Secuado, Xelstrym |
| Alkermes, INC. | $23.85 | 2025 | Aristada, Lybalvi |
| Neos Therapeutics, LP | $20.48 | 2024 | Adzenys Xr-Odt |
| Ironshore Pharmaceuticals INC. | $20.36 | 2019 | |
| Avion Pharmaceuticals | $18.97 | 2023 | Methylphenidate Hydrochloride |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lino Fernandez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.